| 常用名 | 2-(2-乙基-2,3-二氢-2-苯并呋喃基)-1H-咪唑 | CAS号 | 189224-48-4 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: KU14R is a new I(3)-R antagonist, which selectively blocks the insulin secretory response to imidazolines.IC50 Value:Target: Insulin ReceptorA new I(3)-R antagonist, KU14R (2 (2-ethyl 2,3-dihydro-2-benzofuranyl)-2-imidazole), which selectively blocks the insulin secretory response to imidazolines. KU14R partially attenuated responses to Imidazole-4-acetic acid-ribotide (IAA-RP). The effects of KU14R on stimulus secretion-coupling in normal mouse islets and beta cells was compared by measuring KATP channel activity, plasma membrane potential, cytosolic calcium concentration ([Ca2+]c) and dynamic insulin secretion. In the presence of 10 mmol/l but not of 5 mmol/l glucose, KU14R (30, 100 or 300 micromol/l) was ineffective. KATP channel was blocked by KU14R (IC50 31.9 micromol/l, Hill slope -1.5). KU14R does not act as an antagonist of either efaroxan or S22068 at an imidazoline site in vivo. 物理化学性质: CAS号:189224-48-4 常用中文名:2-(2-乙基-2,3-二氢-2-苯并呋喃基)-1H-咪唑 常用英文名:KU14R 分子式:C13H14N2O 分子量:214.263 密度:1.2±0.1 g/cm3 沸点:428.1±34.0 °C at 760 mmHg 熔点:137-139ºC 闪点:154.4±15.9 °C 储存条件:Store at RT |